GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Cyclically Adjusted PB Ratio

SymBio Pharmaceuticals (TSE:4582) Cyclically Adjusted PB Ratio : 0.43 (As of Jun. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-01), SymBio Pharmaceuticals's current share price is 円154.00. SymBio Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円360.28. SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 0.43.

The historical rank and industry rank for SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4582' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.33   Med: 0.95   Max: 3.8
Current: 0.42

During the past years, SymBio Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 3.80. The lowest was 0.33. And the median was 0.95.

TSE:4582's Cyclically Adjusted PB Ratio is ranked better than
88.97% of 725 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs TSE:4582: 0.42

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SymBio Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was 円156.377. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円360.28 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


SymBio Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SymBio Pharmaceuticals Cyclically Adjusted PB Ratio Chart

SymBio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.56 2.12 1.41 0.65

SymBio Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.05 0.95 0.65 0.52

Competitive Comparison of SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



SymBio Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=154.00/360.28
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SymBio Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, SymBio Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=156.377/107.2000*107.2000
=156.377

Current CPI (Mar. 2024) = 107.2000.

SymBio Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 882.001 98.000 964.801
201409 858.443 98.500 934.265
201412 859.944 97.900 941.634
201503 810.893 97.900 887.924
201506 782.434 98.400 852.408
201509 738.707 98.500 803.953
201512 547.292 98.100 598.060
201603 469.880 97.900 514.516
201606 527.137 98.100 576.036
201609 495.259 98.000 541.753
201612 471.505 98.400 513.672
201703 445.254 98.100 486.557
201706 391.604 98.500 426.192
201709 232.149 98.800 251.886
201712 239.737 99.400 258.549
201803 230.176 99.200 248.739
201806 223.213 99.200 241.214
201809 242.390 99.900 260.102
201812 237.955 99.700 255.855
201903 217.027 99.700 233.353
201906 222.733 99.800 239.248
201909 158.814 100.100 170.079
201912 166.576 100.500 177.681
202003 157.257 100.300 168.075
202006 164.751 99.900 176.790
202009 142.018 99.900 152.396
202012 122.006 99.300 131.712
202103 116.143 99.900 124.630
202106 115.905 99.500 124.875
202109 130.400 100.100 139.649
202112 175.785 100.100 188.253
202203 178.318 101.100 189.077
202206 212.278 101.800 223.538
202209 224.196 103.100 233.112
202212 215.244 104.100 221.654
202303 215.448 104.400 221.226
202306 210.740 105.200 214.746
202309 193.070 106.200 194.888
202312 170.890 106.800 171.530
202403 156.377 107.200 156.377

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SymBio Pharmaceuticals  (TSE:4582) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


SymBio Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SymBio Pharmaceuticals (TSE:4582) Business Description

Traded in Other Exchanges
Address
5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

SymBio Pharmaceuticals (TSE:4582) Headlines

No Headlines